Is Neoleukin Therapeutics, Inc. (NLTX) a Buy, Sell, or Hold?
NASDAQ : NLTX
Neoleukin Therapeutics, Inc.
$3.49 USD
$0.05 (1.45%)
- Volume
- 109.1K
- Average Volume
- 6.08K
- Market Capitalization
- $8.2M
- P/E Ratio
- -4.42
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $18.80
- Year Low
- $3.42
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.64
Company Overview
NASDAQ
Donna M. Cochener-Metcalfe
Drug Manufacturers - Specialty & Generic
Healthcare
NLTX
7
US
USD
Liquidity Metrics
0.04
10.64
10.64
5.23
0.00
Sales & Valuation
-$
0.00
0.36
-0.09
-3.89
Profitability
$0
-$90.35M
0.00%
0.00%
-45.11%
-45.47%
P/E Metrics
-4.42
0.02
0.02
Analyst Price Target & Rating
0/5
14 Analysts
%
Financial Health Scores
-1.35
2/9
$227.88M
$263.14M
$25.36M
-$42.97M
Key Metrics (TTM)
-$106.83M
0.00
2.69
13.08
-37.88%
-44.78%
-126.71%
-1014.70%
0 days
Company Executives
| Name | Title |
|---|---|
| David Baker | Co-Founder |
| Sean Michael Smith | Interim Chief Financial Officer |
Poll Results
No votes yet today — be the first to share your view!
About Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Stock
Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused on developing immune-based treatments for conditions such as cancer, inflammatory responses, and autoimmune diseases, utilizing its proprietary protein design technology. The company's leading investigational therapy is NL-201, a novel protein meticulously crafted to emulate the therapeutic effects of the IL-2/IL-15 cytokines. This product candidate is intended for the management of various malignancies, including renal cell carcinoma and melanoma. The organization, founded in 2003, was previously known as Aquinox Pharmaceuticals, Inc. before officially changing its name to Neoleukin Therapeutics, Inc. in August 2019. Its operations are based out of Seattle, Washington. ...
Frequently Asked Questions
-
What is the current Neoleukin Therapeutics, Inc. (NLTX) stock price?
-
Neoleukin Therapeutics, Inc.(NASDAQ:NLTX) stock price is $3.49 in the last trading session. During the trading session, NLTX stock reached the peak price of $18.8 while $3.42 was the lowest point it dropped to. The percentage change in NLTX stock occurred in the recent session was 1.45% while the dollar amount for the price change in NLTX stock was $0.05.
-
NLTX's industry and sector of operation?
-
The NASDAQ listed NLTX is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of NLTX?
-
David Baker | Co-Founder
Sean Michael Smith | Interim Chief Financial Officer
|
|
| -
How many employees does NLTX have?
-
Number of NLTX employees currently stands at 7. NLTX operates from 188 East Blaine Street, Seattle, WA 98102, US.
-
Link for NLTX official website?
-
Official Website of NLTX is: https://www.germfalcon.com
-
How do I contact NLTX?
-
NLTX could be contacted at phone #855 226 6447 and can also be accessed through its website. NLTX operates from 188 East Blaine Street, Seattle, WA 98102, US.
-
How many shares of NLTX are traded daily?
-
The average number of NLTX shares traded daily for last 3 months was 6.08K.
-
What is the market cap of NLTX currently?
-
The market value of NLTX currently stands at $8.2M with its latest stock price at $3.49